Evidence map›Paper›PMID 11839803›Full record

ArticleMolecular and cellular biology2002

ARF differentially modulates apoptosis induced by E2F1 and Myc.

Jamie L Russell, John T Powers, Robert J Rounbehler, Pamela M Rogers, Claudio J Conti, David G Johnson

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Germline mutations predisposing to melanoma.Journal of cutaneous pathology · 2020
    Review
  4. Review
  5. Recombinant protein ofOncotarget · 2017
    Article
  6. p75 neurotrophin receptor is a clock gene that regulates oscillatory components of circadian and metabolic networks.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  7. Article
  8. p53 and E2f: partners in life and death.Nature reviews. Cancer · 2009
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  15. Article
  16. Article
  17. The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jamie L RussellDepartment of Carcinogenesis, Science Park-Research Division, University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957, USA.
John T Powers
Robert J Rounbehler
Pamela M Rogers
Claudio J Conti
David G Johnson
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Pilot Project ProgramP30ES007784 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI RICHIE, ELLEN R · 1996 to 2011
$16.4M
DUAL ROLE OF E2F1 IN TUMORIGENESISR01CA079648 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI JOHNSON, DAVID G. · 1999 to 2014
$4.7M
CYCLINS AND CHEMICAL CARCINOGENESISR01CA042157 · NCI · UNIVERSITY OF TEXAS SYSTEM · PI CONTI, CLAUDIO J · 1986 to 2004
$1.2M
NCI NIH HHS CA16672NCI NIH HHS CA42157NCI NIH HHS CA79648NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA042157NCI NIH HHS R01 CA079648NIEHS NIH HHS ES007784NIEHS NIH HHS P30 ES007784
6 · The paper itself

Abstract

The ARF tumor suppressor participates in a p53-dependent apoptotic pathway that is stimulated in response to some oncogenic stimuli. The E2F1 transcription factor is a critical downstream target of the Rb tumor suppressor and, when active, can promote proliferation as well as apoptosis. The finding that E2F1 transcriptionally regulates the ARF gene has led to the suggestion that ARF contributes to E2F1-induced apoptosis. Counter to this hypothesis, this study demonstrates not only that ARF is unnecessary for E2F1 to induce apoptosis but also that inactivation of ARF actually enhances the ability of E2F1 to promote apoptosis. Inactivation of ARF also cooperates with E2F1 activity to promote entry into the S phase of the cell cycle. This relationship between ARF and E2F1 is demonstrated in transgenic epidermis in vivo and in mouse embryo fibroblast cultures in vitro. In contrast, the ability of Myc to induce apoptosis is diminished in the absence of ARF. E2F1 induces the accumulation of p53 in the absence of ARF, and this is associated with the phosphorylation of p53 on several residues. These findings demonstrate that ARF is a negative regulator of E2F1 activity and is not required for E2F1-induced apoptosis.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsAnimalsApoptosisE2F1 Transcription FactorE2F Transcription FactorsEpidermisFibroblastsHumansMiceMice, TransgenicProto-Oncogene Proteins c-mycS PhaseTranscription FactorsTumor Suppressor Protein p14ARFTumor Suppressor Protein p53Cell Cycle ProteinsDNA-Binding ProteinsE2F1 protein, humanE2f1 protein, mouseE2F1 Transcription FactorE2F Transcription FactorsProto-Oncogene Proteins c-mycTranscription FactorsTumor Suppressor Protein p14ARFTumor Suppressor Protein p53

Identifiers

PMID11839803
PMCPMC134697
OpenAlexW2101801927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.